Rh. Derijk et al., CHANGES IN CORTICOSTEROID SENSITIVITY OF PERIPHERAL-BLOOD LYMPHOCYTESAFTER STRENUOUS EXERCISE IN HUMANS, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 228-235
Although plasma corticosteroid concentrations can be measured accurate
ly, the biological effect on the target tissue is uncertain. The avail
ability of an accurate measure of corticosteroid sensitivity would pot
entially clarify the putative roles of endogenous glucocorticoids in i
llnesses such as inflammatory disease and obesity and allow evaluation
of an additional regulatory level of glucocorticoid action. To measur
e corticosteroid sensitivity, we developed an assay based on the inhib
ition by dexamethasone (Dex) of lipopolysaccharide (LPS)-induced Inter
leukin-6 (IL-6) production and release in whole unseparated blood in v
itro. LPS induced a dose-dependent increase in IL-6 concentrations up
to 34 +/- 6.6 ng/mL, reaching plateau levels after 8 h, whereas Dex do
se dependently inhibited LPS-induced IL-6 production. Involvement of t
he glucocorticoid receptor in this response was supported by abrogatio
n of Dex (10(-7) mol/L) inhibition of IL-6 production by the glucocort
icoid receptor antagonist RU 38486. To determine whether corticosteroi
d sensitivity is a dynamic phenomenon, we subjected healthy males to a
graded quantifiable exercise associated with increases in plasma ACTH
and cortisol. Before exercise, 3 x 10(-8) mol/L Dex inhibited LPS-ind
uced IL-6 production in vitro; after exercise, 3 x 10(-8) and 10(-7) m
ol/L Dex were unable to inhibit IL-6 production. We conclude that Dex
suppression of LPS-induced IL-6 production is an effective means of de
termining corticosteroid sensitivity and that corticosteroid sensitivi
ty in human subjects is a dynamic, rather than a static, phenomenon.